Cargando…
The peripheral immune response and lung cancer prognosis
Attempts to refine and improve outcome predictions using tumor gene expression have been recently reported. We show that peripheral blood mononuclear cell (PBMC)-associated gene signatures can predict outcome in non-small cell lung carcinoma patients independent of demographic data or TNM staging, a...
Autores principales: | Showe, Michael K., Kossenkov, Andrew V., Showe, Louise C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518521/ https://www.ncbi.nlm.nih.gov/pubmed/23243612 http://dx.doi.org/10.4161/onci.21096 |
Ejemplares similares
-
Peripheral Immune Cell Gene Expression Predicts Survival of Patients with Non-Small Cell Lung Cancer
por: Kossenkov, Andrew V., et al.
Publicado: (2012) -
POLE proofreading mutation, immune response and prognosis in endometrial cancer
por: van Gool, Inge C., et al.
Publicado: (2015) -
The immune response in HPV(+) oropharyngeal cancer
por: King, Emma V, et al.
Publicado: (2014) -
DNA methylation markers for breast cancer prognosis: Unmasking the immune component
por: Dedeurwaerder, Sarah, et al.
Publicado: (2012) -
Tertiary lymphoid structures in human lung cancers, a new driver of antitumor immune responses
por: Goc, Jérémy, et al.
Publicado: (2014)